- Home
- HYI vs ORMP Comparison
HYI vs ORMP Comparison
Compare HYI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HYI | ORMP |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.8M | 134.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | HYI | ORMP |
|---|---|---|
| Price | $10.74 | $3.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 45.2K | ★ 158.6K |
| Earning Date | 01-01-0001 | 04-06-2026 |
| Dividend Yield | ★ 9.59% | 6.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | ★ $1,340,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.83 | $1.82 |
| 52 Week High | $12.12 | $3.76 |
Technical Indicators
Market Signals| Indicator | HYI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 27.00 | 53.49 |
| Support Level | N/A | $3.21 |
| Resistance Level | $11.21 | $3.76 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 4.55 | 64.96 |
Price Performance
Historical ComparisonAbout HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.